BBLG FY 2019 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

FY 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

-$50

Operating Income

-$2M

Net Income

-$3M

EPS (Diluted)

$-66.97

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$49,692

Balance Sheet

Total Assets

$30,827

Total Liabilities

$12M

Stockholders' Equity

-$12M

Cash & Equivalents

$24,145

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$50	-$96	+47.9%
Operating Income	-$2M	-$3M	+12.3%
Net Income	-$3M	-$4M	+22.7%